ADICET BIO INC. - COMMON STOCK

Adicet Bio Added to the Russell 2000® Index

28 Jun 2021 06:00:00 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

18 May 2021 15:10:00 By Nasdaq GlobeNewswire

Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates

17 May 2021 06:01:00 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit

29 Apr 2021 06:00:03 By Nasdaq GlobeNewswire

Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

15 Apr 2021 06:00:02 By Nasdaq GlobeNewswire

Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research

13 Apr 2021 06:00:00 By Nasdaq GlobeNewswire

Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

11 Mar 2021 15:10:00 By Nasdaq GlobeNewswire

Adicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors

04 Mar 2021 15:01:00 By Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

16 Feb 2021 06:00:01 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

11 Feb 2021 06:00:01 By Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

10 Feb 2021 06:51:22 By Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

09 Feb 2021 15:04:22 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

07 Jan 2021 06:00:00 By Nasdaq GlobeNewswire